Obermatt
See Similar Stocks →

Flags

Financial distress

Sanara MedTech

NAQ:SMTI · US79957L1008
Health Care Equipment & SuppliesSmall

360

52
EV / EBIT17
Price / Owner Earnings82
Owner Earnings Yield1
Dividend Yield1
Price/Sales64
EV / Gross Profit78
Price/Book1
Return on Capital87
Cash Return on Capital4
Return on Equity46
EBIT Margin58
Gross Profitability100
Accruals97
Owner Earnings Margin17
Sales growth81
Profit Growth21
Long-Term EPS Growth35
Reinvestment45
Price momentum46
Debt load13
Refinancing41
Debt Payback1
Liquidity28
Analyst ratings100
Opinion Changes50
Price Target Upside88
Market mood69
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Sanara MedTech clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2001
Employees93
Websitesanaramedtech.com
ISINUS79957L1008
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsOrthopaedicsBiomedical EngineeringSurgeryHealth Care

Description

Sanara MedTech Inc., a medical technology company, focuses on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. The company’s products are designed to a…

Analysis

Middle-of-the-road

Sanara MedTech Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 10/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
6
2023202420252026

All-time high

56

Jan 2023

All-time low

1

Mar 2026

Average rank

18

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
64
44
33
42
Price/Earnings
1
5
5
5
Price/Book
1
16
9
28
Dividend Yield
1
1
1
1
Value (overall)
6
25
4
29

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sanara MedTech with its peers
Bioventus
NSQ:BVS
97
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
TELA Bio
NMQ:TELA
19
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Medline
NSQ:MDLN
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Solventum
NYQ:SOLV
62
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Baxter
NYQ:BAX
2
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Cerus
NMQ:CERS
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →